James S. Polakowski

1.8k total citations
39 papers, 900 citations indexed

About

James S. Polakowski is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Physiology. According to data from OpenAlex, James S. Polakowski has authored 39 papers receiving a total of 900 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 15 papers in Cardiology and Cardiovascular Medicine and 12 papers in Physiology. Recurrent topics in James S. Polakowski's work include Receptor Mechanisms and Signaling (15 papers), Cardiac electrophysiology and arrhythmias (10 papers) and Nitric Oxide and Endothelin Effects (6 papers). James S. Polakowski is often cited by papers focused on Receptor Mechanisms and Signaling (15 papers), Cardiac electrophysiology and arrhythmias (10 papers) and Nitric Oxide and Endothelin Effects (6 papers). James S. Polakowski collaborates with scholars based in United States, United Kingdom and Sweden. James S. Polakowski's co-authors include Bryan F. Cox, Kennan C. Marsh, Craig D. Wegner, Jason A. Segreti, David M. Pollock, Ryan M. Fryer, Chih‐Hung Lee, Jorge D. Brioni, Nathan L. Lubbers and T. J. Opgenorth and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Biochemical and Biophysical Research Communications.

In The Last Decade

James S. Polakowski

38 papers receiving 870 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
James S. Polakowski United States	17	405	172	147	134	111	39	900
Ivan Milicic United States	19	554 1.4×	164 1.0×	151 1.0×	202 1.5×	127 1.1×	42	1.1k
Michael G. Hahn Germany	12	457 1.1×	205 1.2×	70 0.5×	293 2.2×	128 1.2×	26	1.1k
Steven A. Buckner United States	19	434 1.1×	109 0.6×	154 1.0×	112 0.8×	251 2.3×	57	986
Ravi B. Marala United States	13	476 1.2×	258 1.5×	176 1.2×	95 0.7×	107 1.0×	17	790
Roger J. Hill United States	20	720 1.8×	227 1.3×	219 1.5×	197 1.5×	118 1.1×	30	1.2k
Yvonne Vulliemoz United States	16	443 1.1×	209 1.2×	242 1.6×	258 1.9×	46 0.4×	52	1.0k
Hideki Moritoki Japan	20	388 1.0×	258 1.5×	212 1.4×	508 3.8×	88 0.8×	73	1.0k
Youichi Yabuuchi Japan	18	544 1.3×	231 1.3×	132 0.9×	127 0.9×	298 2.7×	62	1.4k
Mümin Alper Erdoğan Türkiye	16	229 0.6×	53 0.3×	112 0.8×	82 0.6×	52 0.5×	98	775
Hideaki Fukushima Japan	18	491 1.2×	81 0.5×	219 1.5×	90 0.7×	247 2.2×	65	1.3k

Countries citing papers authored by James S. Polakowski

Since Specialization

Citations

This map shows the geographic impact of James S. Polakowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James S. Polakowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James S. Polakowski more than expected).

Fields of papers citing papers by James S. Polakowski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James S. Polakowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James S. Polakowski. The network helps show where James S. Polakowski may publish in the future.

Co-authorship network of co-authors of James S. Polakowski

This figure shows the co-authorship network connecting the top 25 collaborators of James S. Polakowski. A scholar is included among the top collaborators of James S. Polakowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James S. Polakowski. James S. Polakowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Belair, David G., Rebecca Kohnken, Rebecca L. McCloud, et al.. (2025). Predicting seizure liability of small molecules using an in vitro multi-electrode array based assay coupled with modeling of brain disposition. Current Research in Toxicology. 8. 100236–100236.

Polakowski, James S., et al.. (2023). Species comparison of compounds with known blood pressure effects in a vascular smooth muscle cell collagen contraction assay. Journal of Pharmacological and Toxicological Methods. 123. 107290–107290. 1 indexed citations

Watson, Mark A., Hoi Shan Wong, Pratiksha Dighe, et al.. (2023). Suppression of superoxide/hydrogen peroxide production at mitochondrial site IQ decreases fat accumulation, improves glucose tolerance and normalizes fasting insulin concentration in mice fed a high-fat diet. Free Radical Biology and Medicine. 204. 276–286. 7 indexed citations

Segreti, Jason A., James S. Polakowski, Eric A.G. Blomme, & Andrew J. King. (2016). Simultaneous measurement of arterial and left ventricular pressure in conscious freely moving rats by telemetry. Journal of Pharmacological and Toxicological Methods. 79. 23–33. 9 indexed citations

Esbenshade, Timothy A., Kaitlin E. Browman, Thomas R. Miller, et al.. (2012). Pharmacological Properties and Procognitive Effects of ABT-288, a Potent and Selective Histamine H3 Receptor Antagonist. Journal of Pharmacology and Experimental Therapeutics. 343(1). 233–245. 38 indexed citations

Curtin, Michael L., Robin R. Frey, H. Robin Heyman, et al.. (2012). Thienopyridine ureas as dual inhibitors of the VEGF and Aurora kinase families. Bioorganic & Medicinal Chemistry Letters. 22(9). 3208–3212. 19 indexed citations

Lee, Chih‐Hung, Chang Zhu, John Malysz, et al.. (2011). α4β2 neuronal nicotinic receptor positive allosteric modulation: An approach for improving the therapeutic index of α4β2 nAChR agonists in pain. Biochemical Pharmacology. 82(8). 959–966. 49 indexed citations

Su, Zhi, Lee C. Preusser, Gilbert Diaz, et al.. (2011). Negative Inotropic Effect of a CB2 Agonist A-955840 in Isolated Rabbit Ventricular Myocytes is Independent of CB1 and CB2 Receptors. Current Drug Safety. 6(5). 277–284. 6 indexed citations

Segreti, Jason A., Kennan C. Marsh, Joy Bauch, et al.. (2010). Tumour‐selective antivascular effects of the novel anti‐mitotic compound A‐318315: Anin vivorat regional haemodynamic study. Clinical and Experimental Pharmacology and Physiology. 37(5-6). 636–640. 3 indexed citations

10.

Polakowski, James S., Andrew King, Thomas Campbell, et al.. (2009). Cardiovascular Effects of Torcetrapib in Conscious and Pentobarbital-anesthetized Dogs. Journal of Cardiovascular Pharmacology. 54(6). 543–551. 12 indexed citations

11.

Segreti, Jason A., Kennan C. Marsh, James S. Polakowski, & Ryan M. Fryer. (2008). Evoked Changes in Cardiovascular Function in Rats by Infusion of Levosimendan, OR-1896 [(R)-N-(4-(4-Methyl-6-oxo-1,4,5,6-tetrahydropyridazin-3-yl)phenyl)acetamide], OR-1855 [(R)-6-(4-Aminophenyl)-5-methyl-4,5-dihydropyridazin-3(2 H)-one], Dobutamine, and Milrinone: Comparative Effects on Peripheral Resistance, Cardiac Output, dP/dt, Pulse Rate, and Blood Pressure. Journal of Pharmacology and Experimental Therapeutics. 325(1). 331–340. 32 indexed citations

12.

Polakowski, James S., Ryan M. Fryer, Gary A. Gintant, Scott W. Mittelstadt, & B. F. Cox. (2008). Comparison of cardiovascular effects in conscious and pentobarbital anesthetized dogs. Journal of Pharmacological and Toxicological Methods. 58(2). 148–148. 1 indexed citations

13.

Brown, Brian S., Ryan G. Keddy, Guo Zhu Zheng, et al.. (2008). Tetrahydropyridine-4-carboxamides as novel, potent transient receptor potential vanilloid 1 (TRPV1) antagonists. Bioorganic & Medicinal Chemistry. 16(18). 8516–8525. 44 indexed citations

14.

Reinhart, Glenn A., Ryan M. Fryer, Mark A. Osinski, et al.. (2005). Predictive, non-GLP models of secondary pharmacodynamics: putting the best compounds forward. Current Opinion in Chemical Biology. 9(4). 392–399. 8 indexed citations

15.

Brioni, Jorge D., Robert B. Moreland, Marlon Cowart, et al.. (2004). Activation of dopamine D ₄ receptors by ABT-724 induces penile erection in rats. Proceedings of the National Academy of Sciences. 101(17). 6758–6763. 100 indexed citations

16.

Lubbers, Nathan L., James S. Polakowski, James D. Crapo, Craig D. Wegner, & Bryan F. Cox. (2003). Preischemic and Postischemic Administration of AEOL10113 Reduces Infarct Size in a Rat Model of Myocardial Ischemia and Reperfusion. Journal of Cardiovascular Pharmacology. 41(5). 714–719. 11 indexed citations

17.

Pollock, David M., James S. Polakowski, T. J. Opgenorth, & Jennifer S. Pollock. (1998). Role of endothelin ETA receptors in the hypertension produced by 4-day l-nitroarginine methyl ester and cyclosporine treatment. European Journal of Pharmacology. 346(1). 43–50. 18 indexed citations

18.

Pollock, David M., James S. Polakowski, Craig D. Wegner, & T. J. Opgenorth. (1997). Beneficial Effect of ET_AReceptor Blockade in a Rat Model of Radiocontrast-Induced Nephropathy. Renal Failure. 19(6). 753–761. 34 indexed citations

19.

Pollock, David M., Barbara J. Divish, James S. Polakowski, & Terry J. Opgenorth. (1993). Effect of the Endothelin ET_AReceptor Antagonist, BQ-123, on Pressor Responses to Endothelin Family Peptides. Endothelium. 1(1). 55–59. 8 indexed citations

20.

Verburg, Kenneth M., James S. Polakowski, Peter Kovar, et al.. (1993). Effects of High Doses of A-74273, a Novel Nonpeptidic and Orally Bioavailable Renin Inhibitor. Journal of Cardiovascular Pharmacology. 21(1). 149–155. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact